Structural and immunological analysis of circumsporozoite protein peptides: A further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine

Vaccine

Volumn 26, Issue 52, 2008, Pages 6908-6918

  Bermúdez, Adriana ^a   Vanegas, Magnolia ^a   Patarroyo, Manuel Elkin ^a  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

Author keywords

CSP; MHC II; NMR; Peptides; Structure

Indexed keywords

ASPARAGINYLSERYLARGINYLSERYLLEUCYLGLYCYLGLUTAMYLASPARAGINYLASPARTYLASPARTYLGLYCY LASPARAGINYLASPARAGINYLGLUTAMYLASPARTYLASPARAGINYLGLUTAMYLLYSYLLEUCYLARGININE; CIRCUMSPOROZOITE PROTEIN; GLYCYLASPARAGINYLGLYCYLGLUTAMINYLGLYCYLHISTIDYLASPARAGINYLMETHIONYLPROLYLASPARAG INYLASPARTYLPROLYLASPARAGINYLARGINYLASPARAGINYLVALYLASPARTYLGLUTAMYLASPARAGINYLA LANYLTYROSINE; HISTIDYLASPARAGINYLMETHIONYLPROLYLASPARAGINYLASPARTYLPROLYLASPARAGINYLARGINYLASP ARAGINYLVALYLASPARTYLGLUTAMYLASPARAGINYLALANYLASPARAGINYLALANYLASPARAGINYLSERYLA LANINE; HLA DR3 ANTIGEN; MALARIA VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; AOTUS; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; IMMUNOGENICITY; IMMUNOLOGY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; AOTUS TRIVIRGATUS; BLOTTING, WESTERN; CIRCULAR DICHROISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HLA-DR ANTIGENS; IMMUNIZATION; MAGNETIC RESONANCE SPECTROSCOPY; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTOZOAN PROTEINS; VACCINES, SUBUNIT;

EID: 56649094378     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.071     Document Type: Article

References (58)

1. Kumar K.A., Sano G., Boscardin S., Nussenzweig R.S., Nussenzweig M.C., Zavala F., et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444 (2006) 937-940
2. Espejo F., Cubillos M., Salazar L.M., Guzman F., Urquiza M., Ocampo M., et al. Structure immunogenicity and protectivity relationship for the 1585 malarial peptide and its substitution analogues. Angew Chem Int Ed Engl 40 (2001) 4654-4657
3. Patarroyo M.E., Cifuentes G., Vargas L.E., and Rosas J. Structural modifications enable conserved peptides to fit into MHC molecules thus inducing protection against malaria. Chembiochem 5 (2004) 1588-1593
4. Coppi A., Pinzon-Ortiz C., Hutter C., and Sinnis P. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J Exp Med 201 (2005) 27-33
5. McCutchan T.F., Kissinger J.C., Touray M.G., Rogers M.J., Li J., Sullivan M., et al. Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci USA 93 (1996) 11889-11894
6. Myung J.M., Marshall P., and Sinnis P. The Plasmodium circumsporozoite protein is involved in mosquito salivary gland invasion by sporozoites. Mol Biochem Parasitol 133 (2004) 53-59
7. Ying P., Shakibaei M., Patankar M.S., Clavijo P., Beavis R.C., Clark G.F., et al. The malaria Circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate. Exp Parasitol 85 (1997) 168-182
8. Dame J.B., Williams J.L., McCutchan T.F., Weber J.L., Wirtz R.A., Hockmeyer W.T., et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225 (1984) 593-599
9. Frevert U., Sinnis P., Cerami C., Shreffler W., Takacs B., and Nussenzweig V. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med 177 (1993) 1287-1298
10. Pancake S.J., Holt G.D., Mellouk S., and Hoffman S.L. Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J Cell Biol 117 (1992) 1351-1357
11. Lawler J., and Hynes R.O. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 103 (1986) 1635-1648
12. Robson K.J., Hall J.R., Jennings M.W., Harris T.J., Marsh K., Newbold C.I., et al. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335 (1988) 79-82
13. Robson K.J., Frevert U., Reckmann I., Cowan G., Beier J., Scragg I.G., et al. Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J 14 (1995) 3883-3894
14. Trottein F., Triglia T., and Cowman A.F. Molecular cloning of a gene from Plasmodium falciparum that code for a protein sharing motifs found in adhesive molecules from mammals and plasmodia. Mol Biochem Parasitol 74 (1995) 129-141
15. Sinnis P., Clavijo P., Fenyo D., Chait B.T., Cerami C., and Nussenzweig V. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med 180 (1994) 297-306
16. Tewari R., Spaccapelo R., Bistoni F., Holder A.A., and Crisanti A. Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity. J Biol Chem 277 (2002) 47613-47618
17. Peterson D.S., Gao Y., Asokan K., and Gaertig J. The circumsporozoite protein of Plasmodium falciparum is expressed and localized to the cell surface in the free-living ciliate Tetrahymena thermophila. Mol Biochem Parasitol 122 (2002) 119-126
18. Urquiza M., Rodriguez L.E., Suarez J.E., Guzman F., Ocampo M., Curtidor H., et al. Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol 18 (1996) 515-526
19. Rodriguez L.E., Urquiza M., Ocampo M., Suarez J., Curtidor H., Guzman F., et al. Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells. Parasitology 120 (2000) 225-235
20. Suarez J.E., Urquiza M., Puentes A., Garcia J.E., Curtidor H., Ocampo M., et al. Plasmodium falciparum circumsporozoite (CS) protein peptides specifically bind to HepG2 cells. Vaccine 19 (2001) 4487-4495
21. Aley S.B., Bates M.D., Tam J.P., and Hollingdale M.R. Synthetic peptides from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium knowlesi recognize the human hepatoma cell line HepG2-A16 in vitro. J Exp Med 164 (1986) 1915-1922
22. van Pelt J.F., Kleuskens J., Hollingdale M.R., Verhave J.P., Ponnudurai T., Meuwissen J.H., et al. Identification of plasma membrane proteins involved in the hepatocyte invasion of Plasmodium falciparum sporozoites. Mol Biochem Parasitol 44 (1991) 225-232
23. Bozdech Z., Llinas M., Pulliam B.L., Wong E.D., Zhu J., and DeRisi J.L. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 1 (2003) E5
24. Cigel F., Batchelder J., Burns Jr. J.M., Yanez D., van der Heyde H., Manning D.D., et al. Immunity to blood-stage murine malarial parasites is MHC class II dependent. Immunol Lett 89 (2003) 243-249
25. Houghten R.A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 82 (1985) 5131-5135
26. Chen Y.H., Yang J.T., and Martinez H.M. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11 (1972) 4120-4131
27. Wüthrich K. NMR of proteins and nucleic acids (1986), John Wiley and Sons, New York
28. Good M.F., Berzofsky J.A., Maloy W.L., Hayashi Y., Fujii N., Hockmeyer W.T., et al. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med 164 (1986) 655-660
29. 1H NMR. J Struct Biol 141 (2003) 115-121
30. Bermudez A., Cifuentes G., Guzman F., Salazar L.M., and Patarroyo M.E. Immunogenicity and protectivity of Plasmodium falciparum EBA-175 peptide and its analog is associated with alpha-helical region shortening and displacement. Biol Chem 384 (2003) 1443-1450
31. Patarroyo M.E., Alba M.P., Vargas L.E., Silva Y., Rosas J., and Rodriguez R. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register. Biochemistry 44 (2005) 6745-6754
32. Collins W.E., Richardson B.B., Sullivan J.S., Morris C.L., and Galland G.G. Infection of Anopheles freeborni mosquitoes on New World monkeys infected with the Uganda I/CDC strain of Plasmodium malariae. J Parasitol 83 (1997) 1099-1103
33. Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q Rev Biophys 31 (1998) 297-355
34. Rodriguez L.E., Curtidor H., Urquiza M., Cifuentes G., Reyes C., and Patarroyo M.E. Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem Rev 108 (2008) 3656-3705
35. 1H NMR. Biochemistry 29 (1990) 7828-7837
36. Ghasparian A., Moehle K., Linden A., and Robinson J.A. Crystal structure of an NPNA-repeat motif from the circumsporozoite protein of the malaria parasite Plasmodium falciparum. Chem Commun (Camb) 2 (2006) 174-176
37. Marsh S.G., Parham P., and Barber L.D. The HLA facts book (2000), Academic Press, New York
38. Herrington D.A., Clyde D.F., Losonsky G., Cortesia M., Murphy J.R., Davis J., et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328 (1987) 257-259
39. Graves P., and Gelband H. Vaccines for preventing malaria (pre-erythrocytic). Cochrane Databas Syst Rev (2006) [CD006198]
40. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Castro Z.R., Nussenzweig R.S., Schmeckpeper B., et al. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccines of defined HLA genotypes. J Infect Dis 182 (2000) 1486-1496
41. Moreno A., Clavijo P., Edelman R., Davis J., Sztein M., Sinigaglia F., et al. CD4 + T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J Immunol 151 (1993) 489-499
42. Calvo-Calle J.M., Hammer J., Sinigaglia F., Clavijo P., Moya-Castro Z.R., and Nardin E.H. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. J Immunol 159 (1997) 1362-1373
43. Nardin E.H., Calvo-Calle J.M., Oliveira G.A., Nussenzweig R.S., Schneider M., Tiercy J.M., et al. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. J Immunol 166 (2001) 481-489
44. Calvo-Calle J.M., Oliveira G.A., and Nardin E.H. Human CD4 + T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites. J Immunol 175 (2005) 7575-7585
45. Calvo-Calle J.M., Oliveira G.A., Watta C.O., Soverow J., Parra-Lopez C., and Nardin E.H. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge. Infect Immun 74 (2006) 6929-6939
46. Parra-Lopez C., Calvo-Calle J.M., Cameron T.O., Vargas L.E., Salazar L.M., Patarroyo M.E., et al. Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein. J Biol Chem 281 (2006) 14907-14917
47. Udhayakumar V., Shi Y.P., Kumar S., Jue D.L., Wohlhueter R.M., and Lal A.A. Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic-T-cell recognition. Infect Immun 62 (1994) 1410-1413
48. Gilbert S.C., Plebanski M., Gupta S., Morris J., Cox M., Aidoo M., et al. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279 (1998) 1173-1177
49. Reece W.H., Pinder M., Gothard P.K., Milligan P., Bojang K., Doherty T., et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 10 (2004) 406-410
50. Stoute J.A., Slaoui M., Heppner D.G., Momin P., Kester K.E., Desmons P., et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med 336 (1997) 86-91
51. Stoute J.A., Kester K.E., Krzych U., Wellde B.T., Hall T., White K., et al. Long-term efficacy and immune responses following immunization with the RTS, S malaria vaccine. J Infect Dis 178 (1998) 1139-1144
52. Pinder M., Reece W.H., Plebanski M., Akinwunmi P., Flanagan K.L., Lee E.A., et al. Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia. Clin Exp Immunol 135 (2004) 286-293
53. Patarroyo M.E., Cifuentes G., and Rodriguez R. Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine. Int J Biochem Cell Biol 40 (2008) 543-557
54. Garcia J.E., Puentes A., and Patarroyo M.E. Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev 19 (2006) 686-707
55. Suarez C.F., Patarroyo M.E., Trujillo E., Estupinan M., Baquero J.E., Parra C., et al. Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages. Immunogenetics 58 (2006) 542-558
56. Moncada C.A., Guerrero E., Cardenas P., Suarez C.F., Patarroyo M.E., and Patarroyo M.A. The T-cell receptor in primates: identifying and sequencing new owl monkey TRBV gene sub-groups. Immunogenetics 57 (2005) 42-52
57. Day M. GPs should use "premier" information sources when prescribing. BMJ 333 (2006) 1239
58. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., and Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217